NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3-Beta resulting in the stabilization of MYCN in human neuroblastomas.
Support:
In contrast, tumors caused in MYCN/NCYM double transgenic mice showed chemo-resistance to the drug.
